Inactive Instrument

Press Releases AMAG Pharmaceuticals, Inc.

Equities

AMAG

US00163U1060

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

AMAG Pharmaceuticals : Files Submission in Response to the Food and Drug Administration's Notice of Opportunity for a Hearing and Proposal to Withdraw Approval of Makena	15/20/15	AQ
AMAG Pharmaceuticals : Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing and Proposal To Withdraw Approval of Makena® (hydroxyprogesterone caproate injection)	14/20/14	PU
AMAG PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifica (form 8-K)	17/20/17	AQ
AMAG PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifica (form 8-K)	17/20/17	AQ
AMAG Pharmaceuticals : Covis Group Completes Acquisition of AMAG Pharmaceuticals	16/20/16	AQ
AMAG Pharmaceuticals : Covis Group Completes Acquisition of AMAG Pharmaceuticals	16/20/16	PR
AMAG PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations: (form 10-Q)	07/20/07	AQ
AMAG PHARMACEUTICALS : REQUESTS HEARING TO MAINTAIN MAKENA AS A TREATMENT OPTION FOR CLINICALLY INDICATED PREGNANT PATIENTS	15/20/15	AQ
AMAG Pharmaceuticals : Covis Group S.à r.l. Announces Commencement of Tender Offer for All Outstanding Shares of AMAG Pharmaceuticals, Inc.	15/20/15	AQ
AMAG Pharmaceuticals : Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for Clinically Indicated Pregnant Patients	15/20/15	AQ
AMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for Clinically Indicated Pregnant Patients	15/20/15	GL
AMAG PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AMAG Pharmaceuticals, Inc. - AMAG	09/20/09	BU
AMAG Pharmaceuticals : Provides Update on FDA's Proposal Regarding Makena	06/20/06	AQ
AMAG PHARMACEUTICALS, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	06/20/06	AQ
AMAG Pharmaceuticals : Provides Update on FDA’s Proposal Regarding Makena® (Hydroxyprogesterone Caproate Injection)	06/20/06	AQ
AMAG Pharmaceuticals Provides Update on FDA’s Proposal Regarding Makena® (Hydroxyprogesterone Caproate Injection)	06/20/06	GL
WeissLaw LLP Investigates AMAG Pharmaceuticals, Inc.	03/20/03	PR
Antares Pharma : Enters Exclusive License Agreement with Ferring Pharmaceuticals For Nocdurna In U.S.	02/20/02	AQ
AMAG Pharmaceuticals : Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals	02/20/02	AQ
AMAG PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	02/20/02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases AMAG Pharmaceuticals, Inc.

Equities

AMAG

US00163U1060

Press Releases

Filters